278. Huge lymphatic malformation with cervicofacial lesion Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 19 / Drugs : 22 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 63
Huge lymphatic malformation with cervicofacial lesion and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
278 | Huge lymphatic malformation with cervicofacial lesion |
6 | Parkinson disease |
46 | Malignant rheumatoid arthritis |
96 | Crohn disease |
158 | Tuberous sclerosis |
17 | Multiple system atrophy |
85 | Idiopathic interstitial pneumonia |
86 | Pulmonary arterial hypertension |
13 | Multiple sclerosis/Neuromyelitis optica |
157 | Sturge-Weber syndrome |
169 | Menkes disease |
170 | Occipital horn syndrome |
167 | Marfan syndrome |
215 | Tetralogy of Fallot |
227 | Osler disease |
22 | Moyamoya disease |
210 | Single Ventricle |
296 | Biliary atresia |
11 | Myasthenia gravis |
113 | Muscular dystrophy |
226 | Interstitial cystitis with Hunners ulcer |
5 | Progressive supranuclear palsy |
70 | Spinal stenosis |
49 | Systemic lupus erythematosus |
2 | Amyotrophic lateral sclerosis |
57 | Idiopathic dilated cardiomyopathy |
281 | Klippel-Trenaunay-Weber syndrome |
111 | Congenital myopathy |
137 | Focal cortical dysplasia |
192 | Cockayne syndrome |
277 | Lymphangiomatosis |